Rigel Pharmaceuticals Stock Forecast - Daily Balance Of Power

RIGL Stock  USD 19.72  0.84  4.09%   
Rigel Stock Forecast is based on your current time horizon. Although Rigel Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Rigel Pharmaceuticals' systematic risk associated with finding meaningful patterns of Rigel Pharmaceuticals fundamentals over time.
  
At this time, Rigel Pharmaceuticals' Inventory Turnover is quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 119.62 this year, although the value of Payables Turnover will most likely fall to 0.95. . The value of Common Stock Shares Outstanding is expected to slide to about 16.5 M. The value of Net Loss is expected to slide to about (70.7 M).
On October 5, 2023 Rigel Pharmaceuticals had Daily Balance Of Power of 0.3529. Balance of Power indicator (or BOP) measures the strength of Rigel Pharmaceuticals market sensitivity to bulls and bears. It estimates the ability of Rigel Pharmaceuticals buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Rigel Pharmaceuticals Balance of Power indicator one can determine a trend of the price direction.
Check Rigel Pharmaceuticals VolatilityBacktest Rigel PharmaceuticalsTrend Details  

Rigel Pharmaceuticals Trading Date Momentum

On October 06 2023 Rigel Pharmaceuticals was traded for  10.20  at the closing time. The top price for the day was 10.50  and the lowest listed price was  9.70 . The trading volume for the day was 85.3 K. The trading history from October 6, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.77% . The trading delta at closing time against the current closing price is 4.72% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Rigel Pharmaceuticals to competition

Other Forecasting Options for Rigel Pharmaceuticals

For every potential investor in Rigel, whether a beginner or expert, Rigel Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Rigel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Rigel. Basic forecasting techniques help filter out the noise by identifying Rigel Pharmaceuticals' price trends.

View Rigel Pharmaceuticals Related Equities

 Risk & Return  Correlation

Rigel Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Rigel Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Rigel Pharmaceuticals' current price.

Rigel Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Rigel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rigel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rigel Pharmaceuticals stock market strength indicators, traders can identify Rigel Pharmaceuticals entry and exit signals to maximize returns.

Rigel Pharmaceuticals Risk Indicators

The analysis of Rigel Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rigel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rigel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Rigel Pharmaceuticals is a strong investment it is important to analyze Rigel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rigel Pharmaceuticals' future performance. For an informed investment choice regarding Rigel Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Rigel Pharmaceuticals to cross-verify your projections.
For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.48)
Earnings Share
0.27
Revenue Per Share
8.979
Quarterly Revenue Growth
0.966
Return On Assets
0.0461
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.